TY - JOUR
T1 - Characterising illness stages and recovery trajectories of eating disorders in young people via remote measurement technology (STORY): A multi-centre prospective cohort study protocol
AU - Kuehne, Carina
AU - Phillips, Matthew
AU - Moody, Sarah
AU - Bryson, Callum
AU - Campbell, Iain
AU - Conde, Pauline
AU - Cummins, Nicholas
AU - Desrivieres, Sylvane
AU - Dineley, Judith
AU - Dobson, Richard
AU - Douglas, Daire
AU - Folarin, Amos
AU - Gallop, Lucy
AU - Hemmings, Amelia
AU - İnce, Başak
AU - Mason, Luke
AU - Rashid, Zulqarnain
AU - Bromley, Alice
AU - Sims, Christopher
AU - Allen, Karina
AU - Bailie, Chantal
AU - Bains, Parveen
AU - Basher, Mike
AU - Battisti, Francesca
AU - Baudinet, Julian
AU - Bristow, Katherine
AU - Dawson, Nicola
AU - Dodd, Lizzie
AU - Frater, Victoria
AU - Freudenthal, Robert
AU - Gripton, Beth
AU - Kan, Carol
AU - Khor, Joel
AU - Kotze, Nicus
AU - Laverack, Stuart
AU - Martin, Lee
AU - Maxwell, Sarah
AU - McDonald, Sarah
AU - McNight, Delysia
AU - McKay, Ruairidh
AU - Merrin, Jessica
AU - Nash, Mel
AU - Nicholls, Dasha
AU - Palmer, Shirlie
AU - Pearce, Samantha
AU - Roberts, Catherine
AU - Serpell, Lucy
AU - Severs, Emilia
AU - Simic, Mima
AU - Staton, Amelia
AU - Westaway, Sian
AU - Sharpe, Helen
AU - Schmidt, Ulrike
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/5/30
Y1 - 2024/5/30
N2 - Background: Eating disorders (EDs) are serious, often chronic, conditions associated with pronounced morbidity, mortality, and dysfunction increasingly affecting young people worldwide. Illness progression, stages and recovery trajectories of EDs are still poorly characterised. The STORY study dynamically and longitudinally assesses young people with different EDs (restricting; bingeing/bulimic presentations) and illness durations (earlier; later stages) compared to healthy controls. Remote measurement technology (RMT) with active and passive sensing is used to advance understanding of the heterogeneity of earlier and more progressed clinical presentations and predictors of recovery or relapse. Methods: STORY follows 720 young people aged 16-25 with EDs and 120 healthy controls for 12 months. Online self-report questionnaires regularly assess ED symptoms, psychiatric comorbidities, quality of life, and socioeconomic environment. Additional ongoing monitoring using multi-parametric RMT via smartphones and wearable smart rings (‘Ōura ring’) unobtrusively measures individuals’ daily behaviour and physiology (e.g., Bluetooth connections, sleep, autonomic arousal). A subgroup of participants completes additional in-person cognitive and neuroimaging assessments at study-baseline and after 12 months. Discussion: By leveraging these large-scale longitudinal data from participants across ED diagnoses and illness durations, the STORY study seeks to elucidate potential biopsychosocial predictors of outcome, their interplay with developmental and socioemotional changes, and barriers and facilitators of recovery. STORY holds the promise of providing actionable findings that can be translated into clinical practice by informing the development of both early intervention and personalised treatment that is tailored to illness stage and individual circumstances, ultimately disrupting the long-term burden of EDs on individuals and their families.
AB - Background: Eating disorders (EDs) are serious, often chronic, conditions associated with pronounced morbidity, mortality, and dysfunction increasingly affecting young people worldwide. Illness progression, stages and recovery trajectories of EDs are still poorly characterised. The STORY study dynamically and longitudinally assesses young people with different EDs (restricting; bingeing/bulimic presentations) and illness durations (earlier; later stages) compared to healthy controls. Remote measurement technology (RMT) with active and passive sensing is used to advance understanding of the heterogeneity of earlier and more progressed clinical presentations and predictors of recovery or relapse. Methods: STORY follows 720 young people aged 16-25 with EDs and 120 healthy controls for 12 months. Online self-report questionnaires regularly assess ED symptoms, psychiatric comorbidities, quality of life, and socioeconomic environment. Additional ongoing monitoring using multi-parametric RMT via smartphones and wearable smart rings (‘Ōura ring’) unobtrusively measures individuals’ daily behaviour and physiology (e.g., Bluetooth connections, sleep, autonomic arousal). A subgroup of participants completes additional in-person cognitive and neuroimaging assessments at study-baseline and after 12 months. Discussion: By leveraging these large-scale longitudinal data from participants across ED diagnoses and illness durations, the STORY study seeks to elucidate potential biopsychosocial predictors of outcome, their interplay with developmental and socioemotional changes, and barriers and facilitators of recovery. STORY holds the promise of providing actionable findings that can be translated into clinical practice by informing the development of both early intervention and personalised treatment that is tailored to illness stage and individual circumstances, ultimately disrupting the long-term burden of EDs on individuals and their families.
KW - eating disorders
KW - recovery
KW - progression
KW - clinical staging
KW - remote measurement technology
KW - longitudinal monitoring
KW - prospective study
KW - observational cohorts
UR - http://www.scopus.com/inward/record.url?scp=85195120896&partnerID=8YFLogxK
U2 - 10.1186/s12888-024-05841-w
DO - 10.1186/s12888-024-05841-w
M3 - Article
SN - 1471-244X
VL - 24
JO - BMC Psychiatry
JF - BMC Psychiatry
IS - 1
M1 - 409
ER -